Free Trial

Biofrontera (BFRIW) Competitors

$0.11 +0.02 (+16.91%)
As of 07/3/2025 02:20 PM Eastern

BFRIW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BTMDW, BCTXW, CALA, and CELUW

Should you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Calithera Biosciences (CALA), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Biofrontera vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Biofrontera$38.00MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Biofrontera Neutral

Summary

Biofrontera beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRIW vs. The Competition

MetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.11B$5.50B$9.02B
Dividend YieldN/A2.92%5.38%4.10%
P/E RatioN/A4.1427.5520.29
Price / SalesN/A545.47389.87112.84
Price / CashN/A10.3536.6357.47
Price / BookN/A11.898.075.68
Net IncomeN/A$21.15B$3.17B$249.04M
7 Day PerformanceN/A2.17%2.83%3.30%
1 Month PerformanceN/A4.88%3.70%5.20%
1 Year PerformanceN/A2.85%35.41%21.37%

Biofrontera Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/A+175.9%$0.00$38.00M0.0070Positive News
ATNFW
180 Life Sciences
N/A$0.01
-4.8%
N/A-19.8%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.13
-21.0%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-47.3%$0.00$585.60M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
+6.5%
N/A-74.1%$0.00N/A0.0015Gap Up
BTMDW
biote
N/A$0.02
+41.3%
N/AN/A$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.07
-15.5%
N/A-70.4%$0.00N/A0.008Gap Down
CALA
Calithera Biosciences
0.6637 of 5 stars
$0.00
flat
N/A-99.0%$0.00N/A0.0060
CELUW
Celularity
N/A$0.04
flat
N/A+100.0%$0.00$54.22M0.00220Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:BFRIW) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners